Literature DB >> 14703194

Is the peritoneum a significant transport barrier in peritoneal dialysis?

Michael Flessner1, Jeffrey Henegar, Steven Bigler, Lori Genous.   

Abstract

OBJECTIVES: The anatomic peritoneum is often considered equivalent to the barrier between the dialysate and the blood, and is also called "the peritoneal membrane." Our hypothesis is that the normal peritoneum is not a significant barrier to solute or water flow. The goal of this study was to explore the effects of alteration of the anatomic peritoneum on the transperitoneal transport of water and solute.
DESIGN: In vivo transport experiments were carried out in control and treated rats. Treatments consisted of frequent mixing of the peritoneal solution versus no mixing, drying the peritoneum prior to the experiment, or selective removal of the entire peritoneum. Transport experiments were carried out via a plastic chamber affixed to the parietal peritoneum. After measuring solute transport or osmotically induced filtration, the tissue underlying the chamber was collected and stained for histology.
RESULTS: Mixing the chamber solution every 5 minutes versus no mixing over 90 minutes did not result in a significant change in the mass transfer coefficient for mannitol (MTCmannitol, n = 14, p > 0.25). Drying the peritoneum prior to the transport experiment did not significantly alter the MTC of albumin or mannitol (n = 17, p > 0.6; n = 19, p > 0.1, respectively). Manual drying did not remove or significantly alter the apparent peritoneal coating on the surface of the mesothelium. Removal of the entire peritoneum did not significantly alter the osmotically induced volume flux from the tissue, nor did it change the MTCmannitol (n = 9, p > 0.9; n = 9, p > 0.4, respectively).
CONCLUSIONS: Mixing of the solution directly over the tissue, manual drying of the peritoneum, or removal of the entire peritoneum does not result in significant alterations in transport. We conclude that the anatomic peritoneum is relatively unimportant as a physical transport barrier in peritoneal dialysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14703194

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  12 in total

Review 1.  Surgical treatment of peritoneal carcinomatosis: current treatment modalities.

Authors:  Yakup Kulu; Beat Müller-Stich; Markus W Büchler; Alexis Ulrich
Journal:  Langenbecks Arch Surg       Date:  2013-11-19       Impact factor: 3.445

2.  Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer.

Authors:  Paul H Sugarbaker; Kurt Van der Speeten; O Anthony Stuart
Journal:  World J Gastrointest Oncol       Date:  2010-01-15

Review 3.  Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin.

Authors:  F Losa; P Barrios; R Salazar; J Torres-Melero; M Benavides; T Massuti; I Ramos; E Aranda
Journal:  Clin Transl Oncol       Date:  2013-06-06       Impact factor: 3.405

Review 4.  Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence.

Authors:  Wim P Ceelen; Michael F Flessner
Journal:  Nat Rev Clin Oncol       Date:  2009-12-15       Impact factor: 66.675

Review 5.  Peritoneal changes in patients on long-term peritoneal dialysis.

Authors:  Raymond T Krediet; Dirk G Struijk
Journal:  Nat Rev Nephrol       Date:  2013-05-14       Impact factor: 28.314

6.  Pharmacokinetics of the perioperative use of cancer chemotherapy in peritoneal surface malignancy patients.

Authors:  K Van der Speeten; K Govaerts; O A Stuart; P H Sugarbaker
Journal:  Gastroenterol Res Pract       Date:  2012-06-13       Impact factor: 2.260

7.  Monitoring of the peritoneal membrane.

Authors:  Dirk G Struijk
Journal:  NDT Plus       Date:  2008-10

8.  The relationship between effluent potassium due to cellular release, free water transport and CA125 in peritoneal dialysis patients.

Authors:  Annemieke M Coester; Machteld M Zweers; Dirk R de Waart; Raymond T Krediet
Journal:  NDT Plus       Date:  2008-10

9.  Quantitative Histomorphometry of the Healthy Peritoneum.

Authors:  Betti Schaefer; Maria Bartosova; Stephan Macher-Goeppinger; Akos Ujszaszi; Markus Wallwiener; Joanne Nyarangi-Dix; Peter Sallay; Dorothea Burkhardt; Uwe Querfeld; Viktoria Pfeifle; Bernd Lahrmann; Vedat Schwenger; Elke Wühl; Stefan Holland-Cunz; Franz Schaefer; Claus P Schmitt
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

Review 10.  Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy.

Authors:  Kurt Van der Speeten; Oswald Anthony Stuart; Paul H Sugarbaker
Journal:  Curr Drug Discov Technol       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.